An anti-CD52 antibody for highly active multiple sclerosis
Alemtuzumab
A specialist drip used in short courses to treat highly active relapsing multiple sclerosis, with long-term safety monitoring.
What is Alemtuzumab?
Alemtuzumab is a specialist medicine used to treat highly active relapsing multiple sclerosis, a condition where the immune system attacks the nervous system in flare-ups. It is an antibody that targets and clears certain immune cells, after which the immune system rebuilds itself, which can reduce relapses for a long time. It is given as a drip into a vein in short courses, usually a year apart, rather than continuously. It needs very close, long-term monitoring because it can cause other immune conditions, particularly affecting the thyroid, kidneys and blood, even years after a course. It is used under a specialist MS service.
Education and reference only. This is a plain-language guide to Alemtuzumab — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Alemtuzumab is a medicine used to treat highly active relapsing multiple sclerosis, an autoimmune condition in which the body's immune system attacks the protective covering of nerves, causing flare-ups (relapses) of symptoms. It is a monoclonal antibody, a laboratory-made protein that targets a marker called CD52 on certain immune cells and clears them from the blood. The immune system then gradually rebuilds, which is thought to reset its behaviour and reduce attacks. It is given as a drip into a vein over a few days in short courses, typically with a long gap between courses, under the care of a specialist MS service.
How it works
Alemtuzumab attaches to a marker called CD52 found on certain white blood cells, including the immune cells that drive the attacks in multiple sclerosis, and clears them from the bloodstream. Over the following months and years the immune system repopulates with new cells, and this rebuilt immune system tends to be less likely to attack the nervous system, which can keep relapses down for a long time after just one or two courses. Because the immune system is reset and rebuilds in an unpredictable way, it can sometimes start attacking other parts of the body, such as the thyroid, kidneys or blood cells, which is why monitoring continues for years after treatment.
Company & origin
Originated / developed by: Specialist manufacturer.
A specialist medicine used in the UK to treat highly active relapsing multiple sclerosis, given as a drip into a vein in short courses with close monitoring.
Practical use
How to take Alemtuzumab
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- It is given as a drip into a vein over several days in a short course, with courses usually about a year apart, arranged by your MS team.
- Expect to be given other medicines around each course to reduce infusion reactions and the risk of certain infections.
- Commit to the long-term blood and urine monitoring for several years after your last course, as serious problems can appear late.
- Report symptoms such as a racing heart, swelling, unusual bruising or blood in the urine promptly between appointments.
- Tell your team about any signs of infection, as your immune system is affected for a time after each course.
Weighing it up
Advantages & disadvantages of Alemtuzumab
Advantages
- Can strongly reduce relapses in highly active multiple sclerosis after only a short course of treatment.
- Given as courses spaced about a year apart rather than as a continuous daily medicine.
- Its benefits can last for a long time after treatment in many people.
Disadvantages
- Needs intensive, long-term monitoring for several years because of the risk of new autoimmune conditions.
- Can cause infusion reactions and increase the risk of certain infections around each course.
- Must be given as a drip in hospital and is reserved for highly active disease.
Practical use
Good to know
The most important thing to understand about alemtuzumab is that, although it is given as only a short course of drips, its effects and risks last for years, so the long-term monitoring that comes with it is not optional. Because it resets the immune system, it can trigger new autoimmune conditions long after a course, most commonly affecting the thyroid, but also sometimes the kidneys or the blood cells that help clotting, which is why you have regular blood and urine tests for several years. Around each course you are given other medicines to lower the risk of infusion reactions and of certain infections, and you should report symptoms such as a racing heart, swelling, unusual bruising, blood in the urine or feeling generally unwell. It is reserved for highly active disease and is used only under a specialist MS service that arranges the monitoring programme.
Who should not take it / use with caution
- People who have had a serious allergic reaction to alemtuzumab should not have it.
- It is used with great caution, or avoided, in people with certain active infections or other autoimmune conditions, decided by the specialist team.
- It should only be used under a specialist MS service that provides the full monitoring programme; pregnancy is planned around treatment with specialist advice.
Monitoring
- Regular blood and urine tests for several years after the last course, to catch late autoimmune problems.
- Checking thyroid function over the long term, as thyroid conditions are a common late effect.
- Watching for signs of infection, kidney problems or unusual bruising and bleeding between appointments.
Side effects
- Infusion reactions such as rash, headache, fever or a racing heart around the time of the drip.
- New autoimmune conditions, especially affecting the thyroid, sometimes years later.
- Less commonly, kidney problems or a drop in the blood cells that help clotting, and a raised risk of infections.
Key interactions
- Other medicines that affect the immune system add to the risk of infection, so this is reviewed by your team.
- Live vaccines are generally avoided around treatment, and your team will advise on vaccination timing.
- Tell your team about all your medicines, as a full list helps keep treatment safe.
Available as: A solution given as a drip into a vein.
Answers
Alemtuzumab: frequently asked questions
What is alemtuzumab used for?
It is used to treat highly active relapsing multiple sclerosis by clearing certain immune cells, after which the immune system rebuilds in a way that tends to reduce relapses.
Why is it given in short courses?
It is given as a drip over a few days in a course, usually about a year apart, because its effect on the immune system lasts long after the medicine itself has gone.
Why do I need monitoring for years?
Resetting the immune system can sometimes trigger new autoimmune conditions, often affecting the thyroid, kidneys or blood, even years later, so regular tests continue for a long time.
What symptoms should I report?
Tell your team promptly about a racing heart, swelling, unusual bruising, blood in the urine or feeling generally unwell, as these can be signs of late side effects.
Is it a first treatment for MS?
No. It is reserved for highly active disease and is used under a specialist MS service because of its risks and the monitoring it requires.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.